You are here: Industry Insights > Treatment

News List

Losartan could improve ovarian cancer treatment europeanpharmaceuticalreview
January 17, 2019
Researchers have found that losartan could be beneficial for those undergoing cancer treatment as it may enhance its effectiveness…
Bayer's Jivi garners EU approval for treatment, prophylaxis of haemophilia A firstwordpharma
November 28, 2018
Bayer said Tuesday that the European Commission approved the recombinant Factor VIII (rFVIII) replacement therapy Jivi for the treatment and prophylaxis of bleeding in previously treated patients 12 years of age or older with haemophilia A. The therapy, f
Phase 3 failure of asthma therapy sends Vectura's ailing shares falling pharmafile
November 28, 2018
Vectura has announced it is terminating development of its severe asthma therapy VR475, an inhaled formulation of the corticosteroid budesonide, after it failed in Phase 3 trials to demonstrate...
Big Data and AI provide better diagnosis and treatment europeanpharmaceuticalreview
November 27, 2018
MedUni Vienna researchers have developed a way to use retinal imaging to diagnose diabetes, explaining how the technique could be used for other conditions…
In clinical trials, new antibody therapy controls HIV for months after treatment worldpharmanews
September 29, 2018
To remain healthy, people infected with HIV must therefore adhere to strict medication regimens, which typically involve ingesting pills every day for the rest of their lives.
NHS summer performance hits new lows pharmatimes
September 18, 2018
Alarm bells over the NHS’ ability to cope with looming winter pressures are ringing again after some aspects of service performance...
FDA approves new kind of treatment for hairy cell leukemia worldpharmanews
September 14, 2018
The U.S. Food and Drug Administration today approved Lumoxiti (moxetumomab pasudotox-tdfk) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemi
ProQR drug for rare childhood blindness succeeds in early trial financialexpress
September 06, 2018
The early trial tested the RNA-based drug, QR-110, in 10 patients with a certain genetic mutation that resulted in an eye disorder called Leber’s congenital amaurosis 10
Pfizer terminates domagrozumab (PF-06252616) clinical studies for the treatment of Duchenne muscular dystrophy worldpharmanews
September 06, 2018
Pfizer Inc. (NYSE: PFE) announced that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension
Eisai gets marketing approval from EC for LENVIMA biospectrumasia
August 24, 2018
As First-Line Treatment in Adults with Advanced or Unresectable Hepatocellular Carcinoma

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page